当前位置:
X-MOL 学术
›
Main Group Chem.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Development, characterization and optical activity evaluation of three new benzimidazole compounds
Main Group Chemistry ( IF 1.3 ) Pub Date : 2020-05-23 , DOI: 10.3233/mgc-190885 Liyan Wan 1
Main Group Chemistry ( IF 1.3 ) Pub Date : 2020-05-23 , DOI: 10.3233/mgc-190885 Liyan Wan 1
Affiliation
Three compounds consisting of bis(benzimidazole) ligand, namely {[L1ZnBr2](CH3OH)2} (1), {[L1Co(CH3COO)CH3O]·CH3OH} (2), {[L1(NO3)2]} (3) have been prepared. (L1 = 1,2-bis((1H-benzo[d]imidazol-2-yl)methyl)benzene). Among them, (1)-(2) are complexes and ligand L1 coordinate with metal ions to form extraordinary polyhedron helicate units. (3) is supramolecular. This new study not only enriches the complexs of benzimidazole, but also expands to the research on adsorption, photocatalysis and fluorescence properties.
中文翻译:
三种新型苯并咪唑化合物的开发,表征和旋光性评估
由双(苯并咪唑)配体组成的三种化合物,即{[L1ZnBr2](CH3OH)2}(1),{[L1Co(CH3COO)CH3O]·CH3OH}(2),{[L1(NO3)2]}(3 )已准备好。(L1 = 1,2-双((1H-苯并[d]咪唑-2-基)甲基)苯)。其中,(1)-(2)是配合物,配体L1与金属离子配位形成非常规多面体螺旋单元。(3)是超分子的。这项新的研究不仅丰富了苯并咪唑的配合物,而且扩大了对吸附,光催化和荧光性质的研究。
更新日期:2020-06-30
中文翻译:
三种新型苯并咪唑化合物的开发,表征和旋光性评估
由双(苯并咪唑)配体组成的三种化合物,即{[L1ZnBr2](CH3OH)2}(1),{[L1Co(CH3COO)CH3O]·CH3OH}(2),{[L1(NO3)2]}(3 )已准备好。(L1 = 1,2-双((1H-苯并[d]咪唑-2-基)甲基)苯)。其中,(1)-(2)是配合物,配体L1与金属离子配位形成非常规多面体螺旋单元。(3)是超分子的。这项新的研究不仅丰富了苯并咪唑的配合物,而且扩大了对吸附,光催化和荧光性质的研究。